| Literature DB >> 30483815 |
F Du1, X Liu1, Q Zhu1, Y He1, J Jiang1, T Napawan1, S Jaiswal1, Z Chen2, J Wang3.
Abstract
OBJECTIVES: The aim of this study is to investigate the sex-specific aortic root anatomy in patients with bicuspid aortic valve (BAV). PATIENTS AND METHODS: This retrospective study includes 73 consecutive patients with BAV who underwent CT evaluation before transcatheter aortic valve replacement (TAVR) between July 2013 and April 2017 in the Second Affiliated Hospital of Zhejiang University. RESULT: The size of the annulus, diameter and height of the sinotubular junction (STJ), height of the coronary artery ostia, and dimension of the aorta were measured. Women had significantly smaller annulus parameters (mean diameter: 23.4 ± 1.8 vs. 26.1 ± 2.1 mm; area: 425.3 ± 59.4 vs. 527.4 ± 84.6 mm2; perimeter: 74.3 ± 5.2 vs. 83.2 ± 6.4 mm), and STJ diameter (29.7 ± 3.1 vs. 32.6 ± 4.5 mm) than men (p < 0.01 for all), even after adjustment for their smaller body surface area (BSA). Dimension of aorta and height of right coronary artery were also significantly smaller in women, although not when indexing for the BSA. The left ventricular ejection fraction of women is significantly higher than that of men before discharge (60.2 ± 9.7% vs. 53.7 ± 13.6%, p = 0.01). There were no differences between women and men in the all-cause 30-day and 1‑year mortality.Entities:
Keywords: Aortic root; Aortic valve stenosis; Computed tomography; Sex ratio; Transcatheter aortic valve replacement
Mesh:
Year: 2018 PMID: 30483815 PMCID: PMC7286940 DOI: 10.1007/s00059-018-4740-0
Source DB: PubMed Journal: Herz ISSN: 0340-9937 Impact factor: 1.443
Baseline characteristics and echocardiographic data
| Variables | Total ( | Female ( | Male ( | |
|---|---|---|---|---|
| Age (year) | 74.30 ± 6.15 | 73.70 ± 5.38 | 74.92 ± 6.87 | 0.40 |
| Society of Thoracic Surgery risk of mortality (%) | 5.72 ± 3.80 | 5.83 ± 4.39 | 5.60 ± 3.14 | 0.47 |
| Body mass index (kg/m2) | 22.66 ± 3.03 | 23.26 ± 3.20 | 22.04 ± 2.76 | 0.09 |
| Body surface area (m2) | 1.65 ± 0.16 | 1.6 ± 0.1 | 1.7 ± 0.2 | <0.01 |
| Hypertension | 36 (49.3%) | 16 (43.2%) | 20 (55.6%) | 0.29 |
| Diabetes mellitus | 13 (17.8%) | 5 (13.5%) | 8 (22.2%) | 0.33 |
| Dyslipidemia | 25 (34.2%) | 15 (40.5%) | 10 (27.8%) | 0.25 |
| Prior MI | 1 (1.4%) | 1 (2.7%) | 0 (0%) | 1.00 |
| Prior PCI | 8 (11.0%) | 3 (8.1%) | 5 (13.9%) | 0.68 |
| Prior CABG | 0 (0%) | 0 (0%) | 0 (0%) | – |
| Prior stroke | 1 (1.4%) | 0 (0%) | 1 (2.8%) | 0.49 |
| Peripheral arterial disease | 14 (19.2%) | 6 (16.2%) | 8 (22.2%) | 0.52 |
| Atrial fibrillation/flutter | 15 (20.5%) | 6 (16.2%) | 9 (25.0%) | 0.35 |
| Prior pacemaker | 3 (4.1%) | 2 (5.4%) | 1 (2.8%) | 1.00 |
| NYHA | – | – | – | 0.53 |
| NYHA II | 13 (17.8%) | 6 (16.2%) | 7 (19.4%) | – |
| NYHA III | 33 (45.2%) | 15 (40.5%) | 18 (50.0%) | – |
| NYHA IV | 27 (37.0%) | 16 (43.2%) | 11 (30.6%) | – |
| Chronic obstructive pulmonary disease | 15 (20.5%) | 6 (16.2%) | 9 (25.0%) | 0.35 |
| Dialysis | 1 (1.4%) | 0 (0%) | 1 (2.8%) | 0.49 |
| eGFR (ml/min) | 60.85 ± 22.65 | 63.02 ± 24.32 | 58.61 ± 20.91 | 0.41 |
| Left ventricular ejection fraction (%) | 53.80 ± 14.53 | 55.52 ± 14.91 | 52.03 ± 14.11 | 0.31 |
| Aortic valve mean gradient (mm Hg) | 60.74 ± 18.17 | 63.92 ± 18.88 | 57.47 ± 17.07 | 0.13 |
| Aortic valve maximum velocity (m/s) | 5.00 ± 0.72 | 5.15 ± 0.70 | 4.85 ± 0.72 | 0.08 |
| Aortic valve area (cm2) | 0.55 ± 0.17 | 0.54 ± 0.19 | 0.55 ± 0.14 | 0.79 |
CABG coronary artery bypass graft, eGFR estimated glomerular filtration rate, MI myocardial infarction, PCI percutaneous coronary intervention, NYHA New York Heart Association
Sex-specific anatomic parameters of aortic root
| Parameters | Total ( | Female ( | Male ( | General linear model | |
|---|---|---|---|---|---|
| Maximum diameter (mm) | 27.6 ± 3.0 | 25.8 ± 2.1 | 29.3 ± 2.6 | <0.01 | <0.01 |
| Minimum diameter (mm) | 21.6 ± 2.5 | 20.7 ± 1.9 | 22.7 ± 2.7 | <0.01 | 0.01 |
| Mean diameter (mm) | 24.7 ± 2.4 | 23.4 ± 1.8 | 26.1 ± 2.1 | <0.01 | <0.01 |
| Area (mm2) | 475.7 ± 88.8 | 425.3 ± 59.4 | 527.4 ± 84.6 | <0.01 | <0.01 |
| Area-derived diameter (mm) | 24.5 ± 2.2 | 23.2 ± 1.6 | 25.8 ± 2.1 | <0.01 | <0.01 |
| Perimeter (mm) | 78.7 ± 7.3 | 74.3 ± 5.2 | 83.2 ± 6.4 | <0.01 | <0.01 |
| Perimeter-derived diameter (mm) | 25.0 ± 2.3 | 23.7 ± 1.6 | 26.5 ± 2.1 | <0.01 | <0.01 |
| Diameter (mm) | 31.1 ± 4.1 | 29.7 ± 3.1 | 32.6 ± 4.5 | 0.003 | 0.01 |
| Height (mm) | 23.7 ± 4.7 | 22.7 ± 3.9 | 24.7 ± 5.2 | 0.070 | 0.13 |
| Maximum diameter (mm) | 43.0 ± 4.5 | 41.9 ± 4.4 | 44.2 ± 4.4 | 0.032 | 0.14 |
| Diameter (4 cm) (mm) | 39.3 ± 4.1 | 38.4 ± 3.9 | 40.3 ± 4.1 | 0.040 | 0.23 |
| LM height (mm) | 16.3 ± 3.7 | 15.6 ± 2.9 | 17.0 ± 4.2 | 0.087 | 0.12 |
| RCA height (mm) | 16.7 ± 3.1 | 15.9 ± 2.4 | 17.6 ± 3.6 | 0.021 | 0.06 |
| Aortic root angle (°) | 54.8 ± 9.6 | 54.4 ± 10.1 | 55.3 ± 9.1 | 0.700 | 0.91 |
| Aortic root calcification | – | – | – | 0.210 | – |
| Mild | 4 (5.5%) | 3 (8.1%) | 1 (2.8%) | – | – |
| Moderate | 11 (15.1%) | 8 (21.6%) | 3 (8.3%) | – | – |
| Severe | 26 (35.6%) | 13 (35.1%) | 13 (36.1%) | – | – |
| Massive | 32 (43.8%) | 13 (35.1%) | 19 (52.8%) | – | – |
LM left main coronary artery, RCA right coronary artery, STJ sinotubular junction
Fig. 1Measurement (in mm) of the annulus and ascending aorta: perimeter (a) and mean diameter of annulus (b); maximum diameter of ascending aorta (c) and ascending aorta diameter 4 cm above the annulus (d)
Post-TAVR outcomes
| Outcomes | Total | Female | Male | |
|---|---|---|---|---|
| Mortality | 3 (4.1%) | 2 (5.4%) | 1 (2.8%) | 1.00 |
| ≥Moderate PVL | 7 (10.0%) | 2 (5.6%) | 5 (14.7%) | 0.38 |
| Stroke | ||||
| Disabling stroke | 0 (0%) | 0 (0%) | 0 (0%) | – |
| Nondisabling stroke | 4 (5.5%) | 3 (8.1%) | 1 (2.8%) | 0.63 |
| New pacemaker implantation | 6 (8.3%) | 4 (10.8%) | 2 (5.7%) | 0.72 |
| Mortality | 3 (4.1%) | 2 (5.4%) | 1 (2.8%) | 1.00 |
| ≥Moderate PVL | 3 (4.6%) | 1 (3.1%) | 2 (6.1%) | 1.00 |
| Stroke | ||||
| Disabling stroke | 0 (0%) | 0 (0%) | 0 (0%) | – |
| Nondisabling stroke | 5 (6.8%) | 4 (10.8%) | 1 (2.8%) | 0.37 |
| New pacemaker implantation | 7 (9.6%) | 4 (10.8%) | 3 (8.3%) | 1.00 |
| Mortality | 6 (10.0%) | 3 (9.4%) | 3 (10.7%) | 1.00 |
| ≥Moderate PVL | 5 (9.6%) | 1 (3.4%) | 4 (17.4%) | 0.22 |
| Stroke | ||||
| Disabling stroke | 0 (0%) | 0 (0%) | 0 (0%) | – |
| Nondisabling stroke | 6 (10.0%) | 5 (15.6%) | 1 (3.6%) | 0.26 |
| New pacemaker implantation | 7 (11.7%) | 4 (12.5%) | 3 (10.7%) | 1.00 |
PVL paravalvular leakage, TAVR transcatheter aortic valve replacement
Fig. 2Echocardiographic data. a Left ventricular ejection fraction (LVEF, %), b mean gradient (mmHg), c maximum velocity (m/s) and d aortic valve area (cm2) across the aortic valve at baseline, in-hospital, 30-day and 1‑year follow-up. *p < 0.05